For research use only
| Cat No. | ABC-TC3844 |
| Product Type | Cord Blood Cells |
| Cell Type | Mononuclear Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cord Blood |
| Disease | Normal |
| Storage | Liquid Nitrogen |
UCB-MNCs contain CD34⁺ HSCs, lymphocytes, and progenitors, enabling multilineage differentiation, immunomodulation, and regenerative medicine applications.
Human Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) are isolated from healthy human umbilical cord blood, containing a heterogeneous population of lymphocytes (T cells, B cells, NK cells), monocytes, and hematopoietic stem/progenitor cells (CD34⁺). These cells are round to slightly irregular in shape, non-adherent in culture, and cryopreserved immediately after isolation. These UCB-MNCs maintain native immune cell properties with higher proportions of naïve T cells (CD45RA⁺) and regulatory T cells (CD4⁺CD25⁺FoxP3⁺) compared to adult peripheral blood. The cells exhibit robust proliferative responses to mitogens (PHA, ConA) and cytokines (IL-2, IL-7), while displaying unique cytokine profiles (elevated IL-10, TGF-β) characteristic of neonatal immunity. Their enriched hematopoietic potential makes them valuable for regenerative medicine research.
| Species | Human |
| Cat.No | ABC-TC3844 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Mononuclear Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cord Blood |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Cord Blood Cells |
| Key Features | – Backed by AcceGen advanced technology – Cryopreserved for highest viability and plating efficiency – Quality-guaranteed for accurate results – Timely technical support for best experimental outcomes |
| Quality Control | All cell lots test negative for HIV-1, HBV, HCV, mycoplasma, yeast, fungi, and other pathogens. |
Human Umbilical Cord Blood Mononuclear Cells provide a readily available source for studying mononuclear cell properties, regenerative capacity, and differentiation potential. Due to their outstanding regenerative capacity, umbilical cord blood mononuclear cells have been widely chosen as the primary source for transplantation in the treatment of nerve and vascular regeneration, such as brain injury/ischemic injury, myocardial infarction and other cell therapies. A variety of subpopulations of mononuclear cells can be isolated from our product for further differentiation and downstream research.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).